Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2003
Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathwayHoon Ryu, Junghee Lee, Beatrix A Olofsson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 1999
Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietinK Zaman, H Ryu, D Hall, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 3, 2006
Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage responseJunghee Lee, Bela Kosaras, Hossein Aleyasin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2015
Daidzein Augments Cholesterol Homeostasis via ApoE to Promote Functional Recovery in Chronic StrokeEunhee Kim, Moon-Sook Woo, Luye Qin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 4, 2008
Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotectionBrett Langley, Melissa A D'Annibale, Kyungsun Suh, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 6, 2022
Hemin-Induced Death Models Hemorrhagic Stroke and Is a Variant of Classical Neuronal FerroptosisMarietta Zille, Juan A Oses-Prieto, Sara R Savage, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 17, 2003
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease miceRobert J Ferrante, James K Kubilus, Junghee Lee, et al.
Chemistry & Biology|April 27, 2010
Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptationNatalya A Smirnova, Ilay Rakhman, Natalia Moroz, et al.
The Journal of Biological Chemistry|October 21, 2004
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's diseaseGabriella Gardian, Susan E Browne, Dong-Kug Choi, et al.
Plos One|April 2, 2013
Derivation of multivariate syndromic outcome metrics for consistent testing across multiple models of cervical spinal cord injury in ratsAdam R Ferguson, Karen-Amanda Irvine, John C Gensel, et al.
Pageof 16